Actelion Submits the Registration Dossier for Macitentan (Opsumit) to the …
Actelion submits the registration dossier for macitentan (Opsumit) to the …
Filed under: drug treatment news 2012
ALLSCHWIL/BASEL, SWITZERLAND – 22 November 2012 – Actelion (SIX: ATLN) today announced that the submission of the Marketing Authorisation Application (MAA) for macitentan (Opsumit®) for the treatment of patients with pulmonary arterial hypertension to …
Read more on Reuters
RECORDATI LICENSES GRASPA(R) FROM ERYTECH IN EUROPE
Filed under: drug treatment news 2012
Milan, 23 November 2012 – Recordati announces that its subsidiary Orphan Europe and Erytech Pharma, a late development stage French biopharmaceutical company focused on orphan oncology and rare diseases, have entered into an agreement granting Orphan …
Read more on Reuters
Report urges move away from prescription drugs to treat chronic pain
Filed under: drug treatment news 2012
A new medical report highlights how Vermont's health care system financially encourages a patient's dependence on opioids, instead of other more effective and less addictive remedies. The report, which was authored by Dr. Cyrus Jordan of the Vermont …
Read more on vtdigger.org
Texas plan to drug-test jobless seeking aid stirs debate
Filed under: drug treatment news 2012
Texas plan to drug-test jobless seeking aid stirs debate. By Peggy Fikac | November 23, 2012 | Updated: November 23, 2012 9:51pm. Comments (0); E-mail; Print. Tweet. Page 1 of 1 … Proponents say drug users' children already are hurting, and that …
Read more on Houston Chronicle